Breastfeeding and antiepileptic drugs

JAMA

Volumn 311, Issue 17, 2014, Pages 1797-1798

  Meador, Kimford J ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; FOLIC ACID; LAMOTRIGINE; PHENYTOIN; VALPROIC ACID;

ANXIETY DISORDER; BEHAVIOR DISORDER; BREAST FEEDING; BREAST MILK; CHILD BEHAVIOR; CHILD DEVELOPMENT; COGNITIVE DEFECT; COHORT ANALYSIS; CONGENITAL MALFORMATION; DEPRESSION; EDUCATION; EPILEPSY; GESTATIONAL AGE; HUMAN; LANGUAGE; MATERNAL AGE; MONOTHERAPY; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; PARITY; POPULATION RESEARCH; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SHORT SURVEY; SMOKING; SOCIAL ADAPTATION; VITAMIN SUPPLEMENTATION;

ANTICONVULSANTS; BREAST FEEDING; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84899857138     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.967     Document Type: Short Survey

References (7)

1. Ip S, Chung M, Raman G, Trikalinos TA, Lau J. A summary of the Agency for Healthcare Research and Quality's evidence report on breastfeeding in developed countries. Breastfeed Med. 2009;4(suppl 1):S17-S30.
2. Veiby G, Engelsen BA, Gilhus NE. Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding. JAMA Neurol. 2013;70(11):1367-1374.
3. Meador KJ, Baker GA, Browning N, et al; NEAD Study Group. Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology. 2010;75(22):1954-1960.
4. Ikonomidou C, Turski L. Antiepileptic drugs and brain development. Epilepsy Res. 2010;88(1):11-22.
5. Hovinga CA, Pennell PB. Antiepileptic drug therapy in pregnancy II. Int Rev Neurobiol. 2008;83:241-258.
6. Veiby G, Daltveit AK, Schjølberg S, et al. Exposure to antiepileptic drugs in utero and child development. Epilepsia. 2013;54(8):1462-1472.
7. Meador KJ, Baker GA, Browning N, et al; NEAD Study Group. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study). Lancet Neurol. 2013;12(3):244-252.